Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels

The carotid atherosclerosis Italian ultrasound study

Damiano Baldassarre, Fabrizio Veglia, Cecilia Gobbi, Giuseppe Gallus, Alessandro Ventura, Gaetano Crepaldi, Maurizio Fisicaro, Silvana Rimondi, Giorgio Ricci, Mario Mancini, M. Gene Bond, Stefano Collatina, Cesare R. Sirtori

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The Carotid Atherosclerosis Italian Ultrasound study (CAIUS), a multicenter, double-blind clinical trial, performed in 305 asymptomatic, moderately hypercholesterolemic patients, clearly demonstrated beneficial effects of pravastatin on the carotid intima-media thickness (IMT) progression. The database of the CAIUS study was examined in order to investigate the presence of a relationship, if any, between the activity of pravastatin on IMT progression rate and its hypocholesterolemic effect. Quantitative B-mode ultrasound imaging was used to quantify the individual mean maximum IMT progression rate in 3 years. In the overall group of patients (placebo and pravastatin) covariance analysis showed that while the variable 'treatment' (0 = placebo, 1 = pravastatin) was significantly related to the reduction of IMT progression (F = 6.6, P = 0.01), the IMT progression did not correlate with the extent of LDL-C lowering (F = 0.00, P = 0.98). To further investigate this issue, the pravastatin treated group was stratified into quartiles of LDL-C reduction. In contrast to what was observed in the placebo group, in which a positive mean IMT progression rate was observed, independent of the extent of LDL-C reduction, no IMT progression was observed in any subgroup treated with pravastatin. No significant difference was found among quartiles and no trend could be identified. In conclusion, the effect of pravastatin treatment on carotid IMT progression rate is beneficial; however the CAIUS study demonstrated that lowering LDL-C by itself, does not explain the variability of beneficial changes in IMT. (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)575-583
Number of pages9
JournalAtherosclerosis
Volume151
Issue number2
DOIs
Publication statusPublished - Aug 2000

Fingerprint

Pravastatin
Carotid Artery Diseases
LDL Cholesterol
Carotid Intima-Media Thickness
Placebos
Multicenter Studies
Ultrasonography
Clinical Trials
Databases
oxidized low density lipoprotein
Therapeutics

Keywords

  • Carotid atherosclerosis
  • IMT progression
  • Long-term therapy
  • Pravastatin
  • Ultrasound

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels : The carotid atherosclerosis Italian ultrasound study. / Baldassarre, Damiano; Veglia, Fabrizio; Gobbi, Cecilia; Gallus, Giuseppe; Ventura, Alessandro; Crepaldi, Gaetano; Fisicaro, Maurizio; Rimondi, Silvana; Ricci, Giorgio; Mancini, Mario; Bond, M. Gene; Collatina, Stefano; Sirtori, Cesare R.

In: Atherosclerosis, Vol. 151, No. 2, 08.2000, p. 575-583.

Research output: Contribution to journalArticle

Baldassarre, Damiano ; Veglia, Fabrizio ; Gobbi, Cecilia ; Gallus, Giuseppe ; Ventura, Alessandro ; Crepaldi, Gaetano ; Fisicaro, Maurizio ; Rimondi, Silvana ; Ricci, Giorgio ; Mancini, Mario ; Bond, M. Gene ; Collatina, Stefano ; Sirtori, Cesare R. / Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels : The carotid atherosclerosis Italian ultrasound study. In: Atherosclerosis. 2000 ; Vol. 151, No. 2. pp. 575-583.
@article{d477d468a1a646f2bc2ef50fcca067fb,
title = "Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: The carotid atherosclerosis Italian ultrasound study",
abstract = "The Carotid Atherosclerosis Italian Ultrasound study (CAIUS), a multicenter, double-blind clinical trial, performed in 305 asymptomatic, moderately hypercholesterolemic patients, clearly demonstrated beneficial effects of pravastatin on the carotid intima-media thickness (IMT) progression. The database of the CAIUS study was examined in order to investigate the presence of a relationship, if any, between the activity of pravastatin on IMT progression rate and its hypocholesterolemic effect. Quantitative B-mode ultrasound imaging was used to quantify the individual mean maximum IMT progression rate in 3 years. In the overall group of patients (placebo and pravastatin) covariance analysis showed that while the variable 'treatment' (0 = placebo, 1 = pravastatin) was significantly related to the reduction of IMT progression (F = 6.6, P = 0.01), the IMT progression did not correlate with the extent of LDL-C lowering (F = 0.00, P = 0.98). To further investigate this issue, the pravastatin treated group was stratified into quartiles of LDL-C reduction. In contrast to what was observed in the placebo group, in which a positive mean IMT progression rate was observed, independent of the extent of LDL-C reduction, no IMT progression was observed in any subgroup treated with pravastatin. No significant difference was found among quartiles and no trend could be identified. In conclusion, the effect of pravastatin treatment on carotid IMT progression rate is beneficial; however the CAIUS study demonstrated that lowering LDL-C by itself, does not explain the variability of beneficial changes in IMT. (C) 2000 Elsevier Science Ireland Ltd.",
keywords = "Carotid atherosclerosis, IMT progression, Long-term therapy, Pravastatin, Ultrasound",
author = "Damiano Baldassarre and Fabrizio Veglia and Cecilia Gobbi and Giuseppe Gallus and Alessandro Ventura and Gaetano Crepaldi and Maurizio Fisicaro and Silvana Rimondi and Giorgio Ricci and Mario Mancini and Bond, {M. Gene} and Stefano Collatina and Sirtori, {Cesare R.}",
year = "2000",
month = "8",
doi = "10.1016/S0021-9150(99)00434-7",
language = "English",
volume = "151",
pages = "575--583",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels

T2 - The carotid atherosclerosis Italian ultrasound study

AU - Baldassarre, Damiano

AU - Veglia, Fabrizio

AU - Gobbi, Cecilia

AU - Gallus, Giuseppe

AU - Ventura, Alessandro

AU - Crepaldi, Gaetano

AU - Fisicaro, Maurizio

AU - Rimondi, Silvana

AU - Ricci, Giorgio

AU - Mancini, Mario

AU - Bond, M. Gene

AU - Collatina, Stefano

AU - Sirtori, Cesare R.

PY - 2000/8

Y1 - 2000/8

N2 - The Carotid Atherosclerosis Italian Ultrasound study (CAIUS), a multicenter, double-blind clinical trial, performed in 305 asymptomatic, moderately hypercholesterolemic patients, clearly demonstrated beneficial effects of pravastatin on the carotid intima-media thickness (IMT) progression. The database of the CAIUS study was examined in order to investigate the presence of a relationship, if any, between the activity of pravastatin on IMT progression rate and its hypocholesterolemic effect. Quantitative B-mode ultrasound imaging was used to quantify the individual mean maximum IMT progression rate in 3 years. In the overall group of patients (placebo and pravastatin) covariance analysis showed that while the variable 'treatment' (0 = placebo, 1 = pravastatin) was significantly related to the reduction of IMT progression (F = 6.6, P = 0.01), the IMT progression did not correlate with the extent of LDL-C lowering (F = 0.00, P = 0.98). To further investigate this issue, the pravastatin treated group was stratified into quartiles of LDL-C reduction. In contrast to what was observed in the placebo group, in which a positive mean IMT progression rate was observed, independent of the extent of LDL-C reduction, no IMT progression was observed in any subgroup treated with pravastatin. No significant difference was found among quartiles and no trend could be identified. In conclusion, the effect of pravastatin treatment on carotid IMT progression rate is beneficial; however the CAIUS study demonstrated that lowering LDL-C by itself, does not explain the variability of beneficial changes in IMT. (C) 2000 Elsevier Science Ireland Ltd.

AB - The Carotid Atherosclerosis Italian Ultrasound study (CAIUS), a multicenter, double-blind clinical trial, performed in 305 asymptomatic, moderately hypercholesterolemic patients, clearly demonstrated beneficial effects of pravastatin on the carotid intima-media thickness (IMT) progression. The database of the CAIUS study was examined in order to investigate the presence of a relationship, if any, between the activity of pravastatin on IMT progression rate and its hypocholesterolemic effect. Quantitative B-mode ultrasound imaging was used to quantify the individual mean maximum IMT progression rate in 3 years. In the overall group of patients (placebo and pravastatin) covariance analysis showed that while the variable 'treatment' (0 = placebo, 1 = pravastatin) was significantly related to the reduction of IMT progression (F = 6.6, P = 0.01), the IMT progression did not correlate with the extent of LDL-C lowering (F = 0.00, P = 0.98). To further investigate this issue, the pravastatin treated group was stratified into quartiles of LDL-C reduction. In contrast to what was observed in the placebo group, in which a positive mean IMT progression rate was observed, independent of the extent of LDL-C reduction, no IMT progression was observed in any subgroup treated with pravastatin. No significant difference was found among quartiles and no trend could be identified. In conclusion, the effect of pravastatin treatment on carotid IMT progression rate is beneficial; however the CAIUS study demonstrated that lowering LDL-C by itself, does not explain the variability of beneficial changes in IMT. (C) 2000 Elsevier Science Ireland Ltd.

KW - Carotid atherosclerosis

KW - IMT progression

KW - Long-term therapy

KW - Pravastatin

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=0033867026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033867026&partnerID=8YFLogxK

U2 - 10.1016/S0021-9150(99)00434-7

DO - 10.1016/S0021-9150(99)00434-7

M3 - Article

VL - 151

SP - 575

EP - 583

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -